| Press Release
BluMaiden Biosciences Pte Ltd
Three Shenton Way #15-01
T (65) 9720 0753
02 August 2021
Professor Kim Lewis
Antimicrobial Discovery Center Northeastern University
Scientific Advisory Board
Professor Kim Lewis – Professor Kim Lewis is a Scientific Advisory Board member at BluMaiden Biosciences. Currently he is a University Distinguished Professor and the Director of Antimicrobial Discovery Center at Northeastern University in Boston, Massachusetts.
Formally he held faculty appointments at Massachusetts Institute of Technology, University of Maryland and Tufts University. A distinguished molecular microbiologist whose research career has focused on the mechanisms of antimicrobial resistance, Lewis is a Fellow of the American Association for the Advancement of Science and a Fellow of the American Acade- my of Microbiology.
Lewis’ research has resolved key problems underpinning the mechanisms by which bacteria can resist the action of antibiotics, discovered new classes of antibiotics and demonstrated the potential of finding antibiotic compounds in microbiomes. Lewis has a long-standing engagement with the biotech industry and pharma. At BluMaiden Biosciences, he is guiding the scientific team on approaches for discovering new therapeutic compounds from human microbiomes.
About BluMaiden Biosciences
BluMaiden Biosciences is an early-stage biotechnology company headquartered in Singapore with the goal of developing microbiome-derived molecular
therapeutics for patients with unmet medical needs. We have integrated a unique computational population-scale data acquisition platform with a therapeutics discovery platform.
BluMaiden Biociences Pte Ltd
Get In Touch
Whether you are a medical practitioner, a patient or would like to learn more, we would love to hear from you